AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its sorted by
relevance

Admin30.09.2021

AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its

8406
Admin05.09.2021

(PDF) AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts

4007
Admin15.07.2021

AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its

2405
Admin25.09.2021

(PDF) AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts

4800
Admin23.07.2021

(PDF) AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts

3701
Admin22.08.2021

AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its

800
Admin04.10.2021

AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its

3808
Admin11.09.2021

AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its

86010
Admin22.07.2021

AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its

6409
Admin08.10.2021

(PDF) Cyclin-Dependent Kinase Inhibitor AT7519 as a

402
Admin05.08.2021

The cyclin-dependent kinase inhibitor AT7519 accelerates

25010
Admin23.09.2021

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential

85010
Admin30.09.2021

(PDF) A Phase I study of cyclin-dependent kinase inhibitor

6006
Admin28.07.2021

Inhibition of Cyclin-dependent Kinase (CDK) Decreased

9305
Admin05.08.2021

(PDF) The cyclin-dependent kinase inhibitor AT7519

4201
Admin06.09.2021

Anticancer and radiosensitizing effects of the cyclin

6200
Admin21.09.2021

(PDF) A Phase I study of cyclin-dependent kinase inhibitor

2507
Admin27.07.2021

APExBIO - AT7519|Multi-CDK inhibitor|CAS# 844442-38-2

8303
Admin22.09.2021

RCSB PDB - 2VTS: Identification of N-(4-piperidinyl)-4-(2

1304
Admin18.07.2021

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential

5606
Admin22.07.2021

(PDF) Cyclin-Dependent Kinase Inhibitor AT7519 as a

7109